BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 87,465 shares, a growth of 82.4% from the October 15th total of 47,962 shares. Based on an average daily volume of 160,195 shares, the short-interest ratio is presently 0.5 days.
BlackRock Health Sciences Term Trust Price Performance
Shares of BMEZ stock traded down $0.10 on Friday, reaching $17.19. 144,839 shares of the company were exchanged, compared to its average volume of 199,763. The company has a 50-day moving average of $16.85 and a 200-day moving average of $15.42. BlackRock Health Sciences Term Trust has a one year low of $13.70 and a one year high of $17.96.
BlackRock Health Sciences Term Trust Announces Dividend
The company also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be paid a dividend of $0.11 per share. This represents a $1.32 dividend on an annualized basis and a yield of 7.7%. The ex-dividend date of this dividend is Friday, December 11th.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in BMEZ. Saba Capital Management L.P. bought a new position in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth $10,907,000. Oppenheimer & Co. Inc. grew its position in BlackRock Health Sciences Term Trust by 96.8% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 197,033 shares of the company’s stock valued at $3,290,000 after purchasing an additional 96,920 shares during the period. Corient Private Wealth LP bought a new stake in BlackRock Health Sciences Term Trust during the 2nd quarter valued at $467,000. Allspring Global Investments Holdings LLC bought a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter valued at $10,855,000. Finally, Rivernorth Capital Management LLC increased its stake in BlackRock Health Sciences Term Trust by 24.8% during the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after purchasing an additional 160,629 shares in the last quarter.
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust is a closed-end investment fund managed by BlackRock Advisors, LLC. Rather than operating healthcare businesses, the trust gives investors exposure to companies in the health sciences and related industries. The fund seeks total return through a combination of income and capital appreciation. It invests primarily in equity securities of health sciences companies, which may include businesses in areas such as pharmaceuticals, biotechnology, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
